DCI Seminar Series (2.22.17)

December 19, 2016
By: Karen E. Butler, Director of Communications, DCI

On Wednesday, Feb. 22, Steven M. Larson, MD, FACNM, FACR, Donna & Benjamin M. Rosen Chair, Attending, Molecular Imaging and Therapy Services, Department of Radiology, Memorial Sloan Kettering Cancer Center, will present “Molecular Imaging and the rise of Radiotheranostics.”

A nuclear medicine physician, Larson focuses on molecular imaging in animals and humans using high-resolution diagnostic instruments, such as positron emission tomography, and single photon emission tomography.

Larson’s laboratory’s primary expertise is in molecular imaging, targeted radio diagnosis, and therapy using small molecules and monoclonal antibodies.He is the corresponding primary investigator of Memorial Sloan Ketterings’s In Vivo Cellular and Molecular Imaging Center (ICMIC) and coleader, with Ingo Mellinghoff and Charles Sawyers, of Research Project 4, studying molecular imaging correlates and biology of activation of the AR-axis in castrate-resistant prostate cancer. This project builds on extensive prior imaging collaborations with prostate cancer specialists Howard Scher, Michael Morris, and Peter Scardino and has led to the development of molecular imaging approaches to androgen receptor (AR) imaging as well as several novel radioantibodies that image downstream effectors of AR signaling.

Presented by DCI’s Radiation Oncology and Imaging Program, the DCI Seminar Series lecture will be held on Wednesday, Feb. 22, in the Trent Semans Center, Great Hall. The lecture begins at 8:10 a.m. and ends at 9 a.m. Larson’s address will be preceded by a hematology-oncology fellow presentation starting at 7:30 a.m. All are invited to attend. For more information, contact Erin Carr.